Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma

Okuda, 2000, Hepatocellular carcinoma, J Hepatol, 32, 225, 10.1016/S0168-8278(00)80428-6 Macdonald, 2001, Pathogenesis of hepatocellular carcinoma, Clin Liver Dis, 5, 69, 10.1016/S1089-3261(05)70154-9 Nakamura, 1984, Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats, Biochem Biophys Res Commun, 122, 1450, 10.1016/0006-291X(84)91253-1 Russell, 1984, Partial characterization of a hepatocyte growth factor from rat platelets, J Cell Physiol, 119, 183, 10.1002/jcp.1041190207 Rubin, 1993, Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product, Biochim Biophys Acta, 1155, 357 Zarnegar, 1995, The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis, J Cell Biol, 129, 1177, 10.1083/jcb.129.5.1177 Matsumoto, 1996, Emerging multipotent aspects of hepatocyte growth factor, J Biochem (Tokyo), 119, 591, 10.1093/oxfordjournals.jbchem.a021283 Nakamura, 1986, Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures, Proc Natl Acad Sci U S A, 83, 6489, 10.1073/pnas.83.17.6489 Ueki, 1997, Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma, Hepatology, 25, 862, 10.1002/hep.510250413 Burr, 1996, Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis, Hepatology, 24, 1282, 10.1002/hep.510240549 Shiota, 1992, Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells, Proc Natl Acad Sci U S A, 89, 373, 10.1073/pnas.89.1.373 Shiota, 1994, Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C, Res Commun Mol Pathol Pharmacol, 85, 271 Liu, 1995, Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine, Carcinogenesis, 16, 841, 10.1093/carcin/16.4.841 Matteucci, 2001, Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells, J Cell Physiol, 186, 387, 10.1002/1097-4652(2000)9999:9999<000::AID-JCP1033>3.0.CO;2-8 Huang, 1999, Tissue hepatocyte growth factor and proliferating cell nuclear antigen in hepatocellular carcinoma, J Formos Med Assoc, 98, 92 Kamiyama, 1998, Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines, Int J Oncol, 12, 655 Neaud, 1997, Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor, Hepatology, 26, 1458, 10.1002/hep.510260612 Perdue, 1984, Chemistry, structure, and function of insulin-like growth factors and their receptors: a review, Can J Biochem Cell Biol, 62, 1237, 10.1139/o84-158 Rechler, 1988, Insulin-like growth factors: polypeptides with diverse physiological roles, Mead Johnson Symp Perinat Dev Med, 32, 12 Sell, 1993, Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor, Proc Natl Acad Sci U S A, 90, 11217, 10.1073/pnas.90.23.11217 Baserga, 1994, The role of the IGF-I receptor in the growth and transformation of mammalian cells, Cell Prolif, 27, 63, 10.1111/j.1365-2184.1994.tb01406.x Cambrey, 1995, Insulin-like growth factor I is a major fibroblast mitogen produced by primary cultures of human airway epithelial cells, Clin Sci, 89, 611, 10.1042/cs0890611 Reape, 1996, IGF-I increases bFGF-induced mitogenesis and upregulates FGFR-1 in rabbit vascular smooth muscle cells, Am J Physiol, 270, H1141 Parrizas, 1997, Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways, J Biol Chem, 272, 154, 10.1074/jbc.272.1.154 Wu, 1996, Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death, J Cell Physiol, 168, 499, 10.1002/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K Caro, 1988, Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver, J Clin Invest, 81, 976, 10.1172/JCI113451 Yakar, 1999, Normal growth and development in the absence of hepatic insulin-like growth factor I, Proc Natl Acad Sci U S A, 96, 7324, 10.1073/pnas.96.13.7324 Su, 1989, Transcripts of the insulin-like growth factors I and II in human hepatoma, Cancer Res, 49, 1773 Stuver, 2000, Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men, Int J Cancer, 87, 118, 10.1002/1097-0215(20000701)87:1<118::AID-IJC17>3.0.CO;2-W Scharf, 2001, The IGF axis in hepatocarcinogenesis, J Clin Mol Pathol, 54, 138, 10.1136/mp.54.3.138 Tsai, 1988, Evidence of autocrine regulation in human hepatoma cell lines, Biochem Biophys Res Commun, 153, 39, 10.1016/S0006-291X(88)81186-0 Zahradka, 1998, Expression and regulation of the insulin-like growth factor-1 receptor by growing and quiescent H4IIE hepatoma, Biochim Biophys Acta, 1375, 131, 10.1016/S0005-2736(98)00144-8 Ellouk-Achard, 1998, Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA, J Hepatol, 29, 807, 10.1016/S0168-8278(98)80263-8 Upegui-Gonzalez, 1998, Use of the IGF-I antisense strategy in the treatment of the hepatocarcinoma, Adv Exp Med Biol, 451, 35, 10.1007/978-1-4615-5357-1_6 Pearson, 2001, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocr Rev, 22, 153 Volmat, 2001, The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases, J Cell Sci, 114, 3433, 10.1242/jcs.114.19.3433 Day, 1999, Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis, Oncogene, 18, 3399, 10.1038/sj.onc.1202683 Yau, 1999, Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation, Eur J Biochem, 266, 1147, 10.1046/j.1432-1327.1999.00968.x McKillop, 1998, Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi-proteins) in experimental hepatocellular carcinoma, J Cell Physiol, 175, 295, 10.1002/(SICI)1097-4652(199806)175:3<295::AID-JCP7>3.0.CO;2-J McKillop, 1999, Inhibitory guanine nucleotide regulatory protein activation of mitogen-activated protein kinase in experimental hepatocellular carcinoma in vitro, Eur J Gastroenterol Hepatol, 11, 761, 10.1097/00042737-199907000-00014 Schini-Kerth, 1999, Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells, J Endocrinol Invest, 22, 82 Tsukahara, 1994, Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells, Kidney Int, 45, 598, 10.1038/ki.1994.78 Skrtic, 1999, Insulin-like growth factor signaling pathways in rat hepatic stellate cells: importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production, Endocrinology, 140, 5729, 10.1210/endo.140.12.7166 Tsukada, 2001, High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2, J Biol Chem, 276, 40968, 10.1074/jbc.M010890200 Schmidt, 1997, Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma, Hepatology, 26, 1189, 10.1002/hep.510260516 McKillop, 1999, Inhibitory guanine nucleotide regulatory protein activation of mitogen-activated protein kinase in experimental hepatocellular carcinoma in vitro, Eur J Gastroenterol Hepatol, 11, 761, 10.1097/00042737-199907000-00014 Kuemmerle, 2001, Coupling of the insulin-like growth factor-I receptor tyrosine kinase to Gi2 in human intestinal smooth muscle: Gβγ-dependent mitogen-activated protein kinase activation and growth, J Biol Chem, 276, 7187, 10.1074/jbc.M011145200 Hallak, 2000, Association of heterotrimeric Gi with the insulin-like growth factor-I receptor. Release of G(βγ) subunits upon receptor activation, J Biol Chem, 275, 2255, 10.1074/jbc.275.4.2255 Dunn, 2000, The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy, Mol Carcinog, 27, 10, 10.1002/(SICI)1098-2744(200001)27:1<10::AID-MC3>3.0.CO;2-Z Dunn, 2001, Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase, Cancer Res, 61, 1367